Kathleen Moore to Neoplasms, Cystic, Mucinous, and Serous
                            
                            
                                This is a "connection" page, showing publications Kathleen Moore has written about Neoplasms, Cystic, Mucinous, and Serous.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.674
         
        
        
     
 
    
        
        - 
            Contribution of age to clinical trial enrollment and tolerance with ovarian cancer. Gynecol Oncol. 2017 04; 145(1):32-36.
            
            
                Score: 0.536
             
- 
            Evaluation of the efficacy and toxicity profile associated with intraperitoneal chemotherapy use in older women. Gynecol Oncol. 2017 08; 146(2):268-272.
            
            
                Score: 0.138